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ABSTRACT
The structure-specific Mus81-Eme1/Mms4 endo-
nuclease contributes importantly to DNA repair
and genome integrity maintenance. Here, using
budding yeast, we have studied its function and
regulation during the cellular response to DNA
damage and show that this endonuclease is neces-
sary for successful chromosome replication and cell
survival in the presence of DNA lesions that interfere
with replication fork progression. On the contrary,
Mus81-Mms4 is not required for coping with repli-
cative stress originated by acute treatment with
hydroxyurea (HU), which causes fork stalling.
Despite its requirement for dealing with DNA
lesions that hinder DNA replication, Mus81-Mms4
activation is not induced by DNA damage at replica-
tion forks. Full Mus81-Mms4 activity is only acquired
when cells finish S-phase and the endonuclease
executes its function after the bulk of genome rep-
lication is completed. This post-replicative mode of
action of Mus81-Mms4 limits its nucleolytic activity
during S-phase, thus avoiding the potential
cleavage of DNA substrates that could cause
genomic instability during DNA replication. At the
same time, it constitutes an efficient fail-safe mech-
anism for processing DNA intermediates that
cannot be resolved by other proteins and persist
after bulk DNA synthesis, which guarantees the
completion of DNA repair and faithful chromosome
replication when the DNA is damaged.
INTRODUCTION
Coping with DNA damage during chromosome replica-
tion is a major challenge for cells. An effective DNA
damage response is essential for faithful chromosome du-
plication and genome integrity maintenance, and requires
the coordination of checkpoints with multiple pathways
and different proteins that are involved in DNA repair
(1–5). Among them, structure-speciﬁc endonucleases
contribute importantly to genomic stability by cleaving
some DNA secondary intermediates that are generated
during replication-associated repair and need nucleolytic
resolution (6–10).
Mus81-Eme1/Mms4 is an evolutionarily conserved
structure-speciﬁc endonuclease involved in the cellular
response to DNA damage (8,11). Yeast cells lacking the
catalytic (Mus81) or the non-catalytic subunit (Mms4 in
Saccharomyces cerevisiae, Eme1 in Schizosaccharomyces
pombe and human cells) of this complex show sensitivity
to a variety of DNA-damaging agents that interfere with
DNA replication (12–17). Likewise, mammalian cells de-
ﬁcient in MUS81 or EME1 are sensitive to some agents
that cause DNA lesions (18–21), and this endonuclease is
necessary for the repair of broken DNA replication forks
(RFs) (22,23). Genetic analyses showed that Mus81-
Eme1/Mms4 is required for cell viability in the absence
of components of the complex formed by the RecQ-
helicase Sgs1, Top3 and Rmi1 in budding yeast (BLM-
TOPIIIa-RMI1-RMI2 in human cells) (13,15,16,24–28),
indicating overlapping functions between Mus81 and
RecQ-helicase complexes. Mus81-Mms4 also has func-
tional overlap with the Yen1 resolvase during DNA
repair (29–32). The synthetic lethality between Mus81
and RecQ complexes is suppressed by eliminating early
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steps of homologous recombination (16,24–26), which
together with its interaction with Rad54 (14) suggested a
role for Mus81-Eme1/Mms4 during recombination-
mediated DNA repair (11). Nevertheless, this nuclease is
not required for the repair of double-strand breaks
through homologous recombination, as mus81/mms4
mutants are not sensitive to g-irradiation (12–14).
Although it is still unclear which are the substrates of
Mus81-Eme1/Mms4 in the cell, a number of biochemical
studies have shown that it can cleave different branched
DNA structures in vitro, all of which are its potential
targets in vivo. Thus, it is able to act, with different
afﬁnity, on model RFs, 30-ﬂaps (30-FLs), D-loops,
X- and Y-shaped structures (15,16,24,33–41).
The Mus81-Eme1/Mms4 endonuclease has a signiﬁcant
role in the maintenance of genome stability, but its
nucleolytic activity needs to be strictly regulated to
avoid the undesired opposite effect. The unrestrained
cleavage of potential substrates such as RFs and other
DNA intermediates would have negative consequences
for chromosome replication, and could also lead to the
formation of chromosomal rearrangements or high levels
of chromatid exchanges. Recent studies in budding yeast
have uncovered key features of the regulation of this endo-
nuclease, showing that in an unperturbed mitotic cell cycle
its activity is controlled by Cdc28CDK1- and Cdc5PLK1-
dependent phosphorylation of the non-catalytic subunit
Mms4 (42,43). This phosphorylation is required for the
full nuclease activity of the complex and restricts the
function of Mus81-Mms4 to a narrow period in a
normal cell cycle, just before chromosome segregation
(42,43). A recent report has conﬁrmed this mode of regu-
lation for Mus81-Mms4 and has provided further evidence
of its importance for the maintenance of genomic stability,
showing that the uncontrolled activation of this endo-
nuclease causes deleterious mitotic crossovers and prema-
ture processing of DNA intermediates (44). Human
Mus81-Eme1 is also regulated through phosphorylation
of the non-catalytic subunit, like in budding yeast (42).
In addition, it has been proposed that in human cells,
Mus81 is negatively controlled by Wee1 (45). Interes-
tingly, a recent work has shown that, in S. pombe, the
cell cycle–dependent phosphorylation of Eme1Mms4 is
Cdc2CDK1-dependent but Plo1PLK1-independent (46),
unlike in budding yeast and human cells, thus showing
differences among organisms in the way that Mus81-
Eme1/Mms4 is regulated. Moreover, in ﬁssion yeast,
Eme1Mms4 hyperphosphorylation is stimulated when cells
are treated with camptothecin or bleomycin. This induced-
hyperphosphorylation is Rad3-dependent and increases
the activity of S. pombe Mus81-Eme1 (46).
Despite the recent ﬁndings on Mus81-Eme1/Mms4
regulation and its established function in the resistance
to some DNA-damaging agents that hinder chromosome
replication, it is still largely unknown how this endonucle-
ase operates when cells need to cope with DNA damage at
RFs. Mus81-Eme1/Mms4 is known to be crucial for
dealing with DNA lesions such as those induced by the
model DNA-damaging agent methyl methanesulfonate
(MMS), which interfere with RF progression. Yet,
because this endonuclease can cleave DNA RFs, its
activity must be carefully controlled somehow under
these situations of DNA damage. Although above-men-
tioned works have shown that Mus81-Mms4 is activated
when cells ﬁnish S-phase in the absence of damaged DNA
(42,43), and in S. pombe its activity is enhanced by some
DNA-damaging drugs in G2-cells (46), it is currently
unclear how Mus81-Mms4 is regulated in response to
DNA lesions occurring during replication. Here, we
have analysed the role of budding yeast Mus81-Mms4
under conditions of DNA damage during S-phase and
show that this endonuclease is necessary for successful
chromosome replication when cells are exposed to
MMS. However, our data indicate that Mus81-Mms4 ac-
tivation is not induced by the presence of DNA lesions
and that its function to respond to DNA damage, which
allows cell survival, is carried out after completion of bulk
genome replication.
MATERIALS AND METHODS
Strains, media, cell cycle synchronization, cell viability
The yeast strains used in this work were constructed by
standard procedures and are listed in Supplementary
Table S1. The pYM (47) and the pML (48) plasmid
series were used as templates for polymerase chain reac-
tion. Yeast cells were grown at 30C in YP medium (1%
yeast extract, 2% bacto peptone) with 2% glucose. Bacto
agar (2%) was added for solid medium. For gene expres-
sion using the GAL1-10 promoter, the YP medium was
supplemented with 2% rafﬁnose or 2% galactose. The a-
factor mating pheromone was added to a ﬁnal concentra-
tion of 5–10 mg/ml to synchronize cells in G1-phase. HU
was used at 0.2M to block cells in early S-phase.
Nocodazole was used at 5 mg/ml to block cells in G2/M.
Samples for ﬂow cytometry were collected and processed
as described (49), and analysed using a FACSCalibur ﬂow
cytometer (BD Biosciences). For ﬂuorescence microscopy
analysis, cells were grown in minimal medium supple-
mented with yeast synthetic drop out (Sigma-Aldrich).
Living cells were analysed using an Axiovert200 Zeiss
ﬂuorescence microscope with a 63 oil immersion object-
ive. Cell viability was determined by plating cells in trip-
licate onto YP-glucose (YPD) plates and counting colony-
forming units after 3 days of incubation at 30C.
Immunoblotting and in situ kinase assay
Protein extracts for immunoblotting analysis were
prepared from trichloroacetic acid-treated cells as
described (50). HA-tagged proteins were detected with
the 12CA5 antibody (CBMSO), using horseradish perox-
idase–coupled anti-mouse (Vector Labs) as a secondary
antibody. Rad53 was detected with the JDI48 antibody (a
gift from Dr J. Difﬂey, Cancer Research UK) and the
horseradish peroxidase–coupled protein A (Invitrogen) as
a secondary antibody. Immunoreactive bands were
visualized using enhanced chemiluminescence (ECL
prime, GE Healthcare). The Rad53 in situ kinase assay
was performed essentially as described (51). For the
authophosphorylation reaction, the membranes (Hybond
P, GE Healthcare) were incubated for 1 h at room
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temperature (RT) in kinase buffer containing 10 mCi/ml
[g-32P]ATP.
Drug sensitivity assays
Logarithmic cultures growing at 30C were normalized to
1 107 cells/ml, and 10-fold serial dilutions were spotted
onto YP plates containing either glucose or galactose and
different concentrations of MMS (Sigma-Aldrich). The
plates were incubated at 30C for 48–72 h.
Dense isotope transfer
Dense isotope substitution experiments were based on (52)
and performed as described (53). The cells were grown for
eight generations at 30C in minimal medium with 0.1%
13C glucose and 0.01% 15N (NH4)2SO4 (CK Gas
Products) (‘heavy medium’). They were then synchronized
in G1, transferred to ‘light’ minimal medium [2% 12C
glucose and 0.01% 15N (NH4)2SO4] and released into
fresh minimal medium either with or without MMS
(0.033%). The DNA was digested with the restriction
enzymes ClaI and SalI, and the digestion products were
separated on CsCl gradients. They were fractionated, and
the fractions were blotted and hybridized with speciﬁc
DNA probes recognizing the ClaI/SalI restriction frag-
ments from chromosome VI (54). DNA replication was
seen as the transfer from the heavy–heavy (HH) peak
(unreplicated DNA), in which the two DNA strands are
substituted with dense isotopes, to the heavy–light (HL)
peak (replicated DNA), where only the parental strand
has the heavy isotopes. The extent of replication was
calculated from the following equation: % replica-
tion=100[0.5 HL/(HH+0.5 HL)].
Pulse ﬁeld gel electrophoresis
Genomic DNA samples were obtained from 108 cells, and
prepared in low melting point agarose plugs, as described
(55). Yeast chromosomes were separated in a 1% agarose-
TBE gel by pulsed-ﬁeld gel electrophoresis (PFGE) at
14C, using a Gene Navigator System, from Pharmacia
Biotech. The electrophoresis were carried out at 180V
(6V/cm) for 24 h, with 90 s, 105 s and 125 s pulses for
9.6, 6 and 8.4 h, respectively. The gels were stained with
ethidium bromide and scanned on a Gel Doc 2000
(Biorad). Quantiﬁcation of the chromosome bands was
performed using the Quantity One program (Biorad).
Nuclease activity assays
The oligonucleotides used to make the DNA substrates
were based on (24). For the construction of a model RF,
the oligonucleotides were RF-1: 50-GACGCTGCCGAAT
TCTGGCGTTAGGAGATACCGATAAGCTTCGGCT
TAAG; RF-2: 50-ATCGATGTCTCTAGACAGCACGA
GCCCTAACGCCAGAATTCGGCAGCGTC; RF-3:
50-CTTAAGCCGAAGCTTATCGGTATCT and RF-4:
50-GCTCGTGCTGTCTAGAGACATCGAT. For the
construction of a 30-FL, the oligonucleotides were RF-1,
RF-2 and RF-4. For the formation of the synthetic
structures used as the substrates in the nuclease assays,
the oligonucleotide RF-1 was 50-32P-labelled using
[g-32P]ATP (Perkin Elmer) and T4 Polynucleotide kinase
(New England Biolabs) and then annealed with an excess
of their complementary oligonucleotides. The annealing
was carried out by heating the DNA molecules for
10min at 80C in 200mM NaCl plus 60mM Tris–HCl
(pH 7.5) buffer, followed by cooling to RT.
Immunoafﬁnity puriﬁcation and nuclease assays were
based on a previously described method (56). HA-Mms4
was immunoafﬁnity puriﬁed from 5 108 cells, which
were disrupted using glass beads in 800 ml of binding
buffer (40mM Tris–HCl, pH 7.5; 100mM AcK; 4%
glycerol; 0.1% NP40; 5mM DTT; 5mM NaF; 5mm
Na4P2O7; protease inhibitors cocktail (2) from Roche—
Complete), and cleared by 40min centrifugation at 4C, top
speed. The supernatant was incubated for 180min at 4C
with 12CA5 antibody and followed by 60min incubation
with 15 ml of Protein A-Sepharose (Sigma-Aldrich). The
Sepharose-bound proteins were centrifuged, washed exten-
sively and used directly for the reactions. The reaction mix-
tures for the nuclease activity assays (25 ml) contained
labelled DNA substrate (40 fmol) in 100mM NaCl,
50mM Tris–HCl, pH 8, 3mM MgCl2, 0.5–1 mg poly[dI-
dC], DTT 0.2mM, plus the afﬁnity puriﬁed tagged-Mms4.
The reactions were incubated for 60min at 30C and
stopped with denaturing stop buffer (ﬁnal concentration:
19% formamide, 4mM EDTA, 0.01% xylene-cyanol and
0.01% bromophenol). The 32P-labelled products were
analysed by electrophoresis through 12.5% denaturing
gels containing 7M urea. Gels were run at constant 23W.
RESULTS
Mus81-Mms4 is important for the cellular response to
DNA damage that originates during S-phase
Cells lacking Mus81-Eme1/Mms4 are sensitive to the
treatment with different DNA-damaging agents, like
the alkylating compound MMS (13–15). To determine
the role of this endonuclease speciﬁcally in replication
over DNA lesions, we restricted DNA damage to a
single S-phase and analysed the consequences of the
absence of Mus81-Mms4. We ﬁrst made null mutants of
the genes encoding the subunits of the Mus81-Mms4
complex in budding yeast, mus81 and mms4, as well
as a double mutant mus81mms4. The strains were
tested for growth on solid medium with MMS. All
mutants grew like wild-type cells in medium without
drug but were much more sensitive to MMS than the
control as expected (Figure 1A). We next studied
S-phase progression in cells treated with MMS and
examined its viability throughout the experiment. For
this, wild-type and mutant cells were synchronized in G1
using a-factor and then released into fresh medium either
without or with MMS, at several concentrations. In all
cases, the cells ﬁnished replication by 60min in medium
without MMS, as shown by ﬂow cytometry, and pro-
gressed later to a new cell cycle (Figure 1B). In contrast,
in the presence of MMS (for simplicity, only the results
with 0.033%MMS are shown), the cells progressed slowly
through S-phase, due to the DNA lesions as shown before
(54,57). Flow cytometry shows that the slow S-phase in
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the three mutants treated with MMS was similar to that of
the control strain (Figure 1B), suggesting that bulk
genome replication is not affected by the absence of
Mus81-Mms4 when the DNA is damaged. However,
unlike the wild-type control, all mutants showed a high
loss of viability during the experiment when treated with
MMS, with no differences among the strains (Figure 1C).
Therefore, although apparently S-phase progression is
similar in wild-type and mus81/mms4 cells exposed to
MMS, cells lacking Mus81-Mms4 might nevertheless
have important chromosome replication defects under
these conditions that severely affect cell survival.
To exclude that the loss of viability observed was an
indirect effect due to a defective S-phase checkpoint in
mus81/mms4 cells, which could yield similar results
(54,57), we monitored checkpoint activation. As the
results obtained in the previous experiments with the
three mutants were identical, we used from now mus81
as the mutant lacking the endonuclease. First, we analysed
the phosphorylation and kinase activity of the checkpoint
protein Rad53 in mus81 cells during S-phase, in the pres-
ence or absence of MMS. The immunoblot (Figure 1D)
showed that Rad53 was only hyperphosphorylated when
mus81 cells were treated with MMS. Moreover, Rad53
phosphorylation correlated with the acquisition of kinase
activity by this protein, as shown by an in situ assay
(Figure 1D) that allows measuring its autophosphory-
lation (51). Second, spindle elongation was analysed in
S-phase cells treated with MMS, using TUB1-GFP. The
data (Figure 1D) show that, like the wild-type control, and
unlike rad53 cells, which cannot restrain mitosis despite
incomplete DNA replication, spindle elongation was in-
hibited in mus81 cells, indicating that the checkpoint
prevents mitosis in this mutant. In summary, cells
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Figure 1. Mus81-Mms4 is necessary to respond to DNA damage occurring during S-phase. (A) Sensitivity to MMS. Serial dilutions (10-fold) of
normalized log-phase cultures were spotted onto YPD plates containing the indicated amounts of MMS and incubated at 30C for 48–72 h.
MUS81+MMS4+ (W303-1a strain); mus81 (YMV39 strain), mms4 (YMV48 strain), mus81 mms4 (YMV49 strain). (B) Cells were synchronized
in G1 and released in medium ±MMS (0.033%). The cells were collected at the indicated time points and the DNA content was determined by ﬂow
cytometry. (C) Cell viability after MMS treatment during S-phase. The different MMS concentrations used are indicated at the top of each panel. (D)
Checkpoint activation. Upper panel: immunoblot analysis of Rad53. Middle panel: in situ autophosphorylation assay for Rad53. Bottom panel:
ﬂuorescence microscopy; G1-blocked cells were released into medium with MMS (0.033%) for 2 h and spindle elongation was analysed. Wild type
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lacking the endonuclease are checkpoint proﬁcient, and
the loss of viability after exposure to MMS during
S-phase is due to the absence of Mus81-Mms4 and not
to a defective checkpoint response. Additionally, these
results indicate that, in the absence of DNA damage,
lack of Mus81-Mms4 did not induce detectable check-
point activation.
Mus81-Mms4 is necessary for successful completion of
chromosome replication under DNA-damaging conditions
The experiments above suggested that cells lacking
Mus81-Mms4 might accumulate severe problems during
replication in the presence of DNA damage, as they
showed a signiﬁcant loss of viability with respect to the
wild-type control despite an apparent similar S-phase pro-
gression (Figure 1B and C). Therefore, it was necessary to
analyse the dynamics of chromosomal replication using
higher resolution approaches than ﬂow cytometry.
We ﬁrst studied the role of this endonuclease in the
replication of damaged DNA by analysing chromosomes
by PFGE, after treating cells with MMS (Figure 2A–C).
MUS81+and mus81 cells were synchronized in G1 with
a factor and then released into S-phase in medium con-
taining MMS. After 60min, the MMS was removed and
the cells were released into fresh medium and allowed to
progress through S-phase. Nocodazole was added to
avoid progression through a new cell cycle, stopping
cells at G2/M. Flow cytometry (Figure 2A) showed that
after 60min with MMS, both MUS81+ and mus81 cells
remained with less than 2C DNA content. After removing
the MMS, both strains progressed similarly through
S-phase and reached the 2C DNA peak, indicating com-
pletion of bulk DNA replication. Consistent with the
results in Figure 1B and C, the viability of MUS81+
cells was high throughout the experiment, whereas it was
reduced in the mus81 mutant (Figure 2B).
The PFGE technique resolves linear chromosomes from
agarose-embedded cells, but DNA containing replication
bubbles remains trapped in the loading wells (58). In both
MUS81+ and mus81 cells, intact chromosomal DNA
from G1-arrested cells was separated as discrete bands.
After 60min MMS treatment in S-phase, no chromosome
bands were detected, indicating ongoing replication in
both strains (Figure 2C), consistent with ﬂow cytometry
(Figure 2A). In MUS81+ cells, full-length chromosomes
started re-entering the gel after 2 h recovery in MMS-
free medium, and by 4 h a high proportion of chromo-
somal DNA appeared as clear bands (about 80% with
respect to the G1-signal), indicating that in most cells
the chromosomes were recovered from the MMS-
induced lesions and completed replication. On the
contrary, in mus81 cells, most of the chromosomal
DNA was retained in the wells 4 h after recovery from
MMS treatment (only 15% with respect to the G1-signal
appeared as discrete bands), showing that it was not com-
pletely replicated. Thus, these results indicate that Mus81-
Mms4 is required for successful chromosome replication
when the DNA is damaged, even when S-phase progres-
sion seems to be completed in both wild-type and mus81
cells (Figure 2A), which in turn explains why cells lacking
the endonuclease lose viability under these conditions
(Figures 1C and 2B). These data are in agreement with a
previous report showing similar results (30), where it was
proposed a function for Mus81 in resolving stalled forks
or recombination intermediates after DNA damage to
allow DNA synthesis.
Although the PFGE data indicate a role for Mus81 in
facilitating the completion of replication under DNA-
damaging conditions, this technique does not show
whether/how fork progression is affected and does not
allow an estimation of the extent of the replication
defects. To study replication in more detail, we used a
second approach based on dense isotope transfer, which
provides a method to study ongoing DNA synthesis at a
particular replicon by analysing the progression of DNA
RFs (52,59,60). Wild-type and mus81 cells were grown in
medium with ‘heavy’ isotopes, synchronized in G1 and
released into medium containing ‘light’ isotopes, either
with or without MMS. The replication of six DNA restric-
tion fragments was analysed in a replicon of 75 kb of
chromosome VI (54), from the early origin ARS607 to
the end of the chromosome (Figure 2D–E). In both
MUS81+ (Figure 2D) and mus81 (Figure 2E) strains,
all DNA fragments were in the HH (unreplicated DNA)
peak in G1-cells (top row). In both strains, the fragments
shifted to the HL (replicated DNA) peak by 60min after
release from G1 medium without MMS (bottom row),
which indicates that they had been replicated. When
MUS81+ cells were released into S-phase in medium
with MMS, the fragment 1 containing ARS607 largely
shifted to the HL position by 30min, and at this time,
there was some HL DNA in fragment 2 (Figure 2D).
Replication progressed rightward: fragment 3 shifted to
the HL peak by 60min and the replication of fragments
4–6 proceeded progressively at later time points (the data
are quantiﬁed at the bottom of Figure 2D). Thus, as pre-
viously described (54,61), DNA RFs move slowly but
efﬁciently through a damaged replicon.
In mus81 cells, the fragment 1 also shifted to the HL
peak by 30min after release from G1 in medium with
MMS (Figure 2E), indicating that the ﬁring of ARS607
occurs like in the wild-type control. Moreover, replication
progressed rightward, as seen by the shifting of the frag-
ments to the HL peak. However, the estimation of the
extent of replication along the replicon indicated that
chromosome replication was compromised in the
absence of Mus81. Thus, at 120min, the percentage of
replicated (HL) DNA in fragments 3–6 was reduced
with respect to the wild type. For example, at this time
point, the number of forks that had passed completely
fragments 5–6 in the mus81 mutant was about three
times less than in the control strain (quantiﬁcation is
shown at the bottom of Figure 2D–E). Later, at
240min, only 43, 30 and 20% of forks in mus81 cells
had passed completely fragments 4, 5 and 6, respectively,
showing defects in the replication of the chromosome
when compared with the MUS81+ strain, in which 63,
57 and 44% of forks passed the same DNA fragments.
Therefore, although bulk DNA replication seems similar
in MUS81+ and mus81 cells (Figures 1B and 2A), more
sensitive assays indicate that chromosome replication in
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the presence of DNA damage is perturbed in cells lacking
Mus81-Mms4. The dense isotope substitution experiments
also show that the absence of this endonuclease does not
cause extensive fork collapse or persistent fork stalling
when cells are treated with MMS. In fact, forks progress
considerably along the studied replicon before clear
chromosomal replication defects are observed at late
time points, when DNA lesions accumulate due to the
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medium with light isotopes, ±MMS (0.033%). RF progression in MUS81+ (D) and mus81 (E) cells was followed in a replicon of chromosome VI,
using DNA probes recognizing the ClaI/SalI fragments 1–6. Probe numbers correspond to fragment numbers. The relative amounts of radioactivity
in the hybridized DNA are plotted against the gradient fraction number. The positions of unreplicated (HH) and fully replicated (HL) peaks are
indicated. The position of the initial HH peak is shown for comparison (grey area). Quantiﬁcation of replication in the presence of MMS for every
fragment and time point is shown at the bottom.
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continued exposure to MMS. Nevertheless, these replica-
tion problems due to the absence of Mus81 are important
enough to account for the incompletion of chromosome
replication observed by PFGE (Figure 2C) as well as for
the reduced viability of mus81 cells under the assayed
DNA-damaging conditions (Figures 1C and 2B).
Mus81-Mms4 is not required to resume DNA replication
after replicative stress caused by acute treatment with HU
We next asked whether Mus81-Mms4 is also necessary to
cope with other kinds of DNA replication perturbations
that, like MMS, cause RF stalling, but unlike this drug,
not necessarily DNA damage. Thus, we studied the
possible involvement of this endonuclease in replication
resumption after replicative stress originated in a single
S-phase by the ribonucleotide reductase inhibitor HU.
There are some apparently contradictory data on the
role of Mus81-Eme1/Mms4 in facilitating DNA replica-
tion after fork stalling caused for HU. For example, mam-
malian Mus81 causes double-strand breaks (DSB) after
prolonged exposure to replicative stress induced by HU
(62,63), and a role for this protein in RF restart after HU
treatment has been proposed (62). However, while mouse
ES cells lacking Mus81 increase their sensitivity to HU
(62), MUS81-depleted U2OS cells exhibit increased resist-
ance to HU (63). On the other hand, although S. pombe
and S. cerevisiae cells lacking Mus81 show sensitivity to
chronic treatment with HU (13,29,30), S. pombe mus81
cells are not signiﬁcantly sensitive to acute exposure to
HU (17), and Mus81 does not have an apparent role in
the resumption of DNA replication after treatment with
this drug in ﬁssion yeast (17). These diverse data could
likely reﬂect distinct biological responses in different
systems to the same challenge, or could be the conse-
quence of different experimental conditions that lead to
different results. Therefore, we decided to analyse the
requirement of budding yeast Mus81-Mms4 for the com-
pletion of chromosome replication after early S-phase
block caused by acute treatment with HU.
MUS81+ and mus81 cells were arrested in G1 with a
factor and then released into S-phase in medium contain-
ing 0.2M HU. It is well established that under the assayed
conditions, DNA replication initiates from early origins
and forks stall within 10 kb from an origin (64). After
90min, the cells were released into medium without HU
and allowed to progress through S-phase. Flow cytometry
(Figure 3A) shows that HU-blocked cells remained with a
DNA content close to 1C. More than 95% of these cells
were budded, conﬁrming release from G1. After removing
HU, MUS81+ and mus81 cells progressed through
S-phase, reached the 2C DNA peak similarly and started
a new cell cycle, indicating that DNA replication and
mitosis proceeded normally. Moreover, both control and
mutant cells maintained high viability after HU treatment
(Figure 3B). These results suggest that the Mus81-Mms4
endonuclease is not necessary for DNA resumption after
blocking forks with HU. The same results were obtained
even if the HU treatment was extended (Supplementary
Figure S1). To discard that the completion of DNA rep-
lication after HU block in the absence of Mus81 was just
due to new replication initiation events that could rescue
remaining stalled forks, we monitored the activation of the
Rad53 checkpoint protein (Figure 3C). As shown in the
immunoblot, Rad53 appeared hyperphosphorylated when
MUS81+ and mus81 cells were treated with HU, which
correlated with its kinase activity (Figure 3C). In both
cases, when HU was removed, Rad53 became dephospho-
rylated and, consistently, no kinase activity was observed.
If there were remaining blocked or collapsed forks owing
to the absence of Mus81-Mms4 after HU treatment, the
checkpoint would continue to be activated, which, in turn,
would block new replication initiation from late replica-
tion origins (64). However, this was not the case, as Rad53
did not remain activated once HU was removed.
Therefore, although new replication initiation is expected
to occur in the experiment, this result reinforces the data
above indicating that the absence of Mus81-Mms4 does
not impede normal fork resumption after HU treatment.
To show more precisely that Mus81-Mms4 was not
required for the response to fork stalling caused by HU,
we analysed chromosomes by PFGE after treating
MUS81+ and mus81 cells with this drug. Both strains
were blocked in G1 and then released into S-phase in
medium with HU, which was subsequently removed.
Nocodazole was added to stop cells in G2/M. Flow
cytometry (Figure 3D, upper panel) showed that both
control and mutant cells reached a 2C DNA content
after release from the HU block, indicating that bulk
DNA synthesis had ﬁnished. PFGE (Figure 3D, lower
panel) showed that intact chromosomes from G1-
blocked cells were separated as discrete bands. In both
strains, chromosomal DNA did not enter the gel after
HU treatment, indicating ongoing replication. In both
MUS81+ and mus81 cells, the chromosomes re-entered
the gel after 60min recovery in medium without HU and
appeared as discrete bands with no differences between
strains, showing that they recovered from the HU block
and ﬁnished replication.
Thus, completely different to the situation in which the
DNA is damaged with MMS, Mus81-Mms4 is not
required for the completion of chromosome replication
when RFs stall due to acute treatment with HU. This
strongly suggests that under these conditions, at least in
budding yeast, Mus81-Mms4 is not involved in the
cleavage of stalled forks that could facilitate recombin-
ation-dependent fork restart.
Mus81-Mms4 activation occurs when cells ﬁnish S-phase,
even in the presence of DNA lesions that interfere with
chromosome replication
The results presented in this work indicate that Mus81-
Mms4 is necessary for chromosome replication under
DNA-damaging conditions. At ﬁrst glance, this might
seem paradoxical, as the regulation of Mus81-Mms4
through Mms4 phosphorylation restrains its normal
function to a narrow period of the cell cycle, just before
chromosome segregation, and maintains the nuclease
activity low during S-phase (42,43). However, Mus81-
Mms4 regulation was previously only studied in an unper-
turbed cell cycle, in the absence of DNA damage. This
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raises the question of whether DNA lesions that interfere
with chromosome replication and reduce cell survival in
the absence of Mus81-Mms4, can induce or modify
somehow the regulation of this endonuclease.
To answer this question, we ﬁrst analysed Mms4 phos-
phorylation in the presence of DNA damage and
compared it with its previously known modiﬁcation in
an unperturbed cell cycle (Figure 4A–C). HA-MMS4
cells were synchronized in G1 and then released in
medium either without or with MMS (Figure 4A–C).
The cells progressed through S-phase and ﬁnished the
cell cycle in medium without MMS (Figure 4A). The
immunoblot (Figure 4A) shows that Mms4 underwent
cell cycle–dependent phosphorylation, as shown before
(42,43). Thus, Mms4 was hyperphosphorylated at 45min
after release from G1, when the cells reached a 2C DNA
content, as shown by an electrophoretic mobility shift, and
became dephosphorylated later, when they progressed
through a new cell cycle. However, in medium with
MMS (Figure 4B), Mms4 did not present changes detect-
able by immunoblotting, even after 120min in the
presence of MMS, a treatment that would have caused a
reduction in cell viability and affected DNA replication in
the absence of Mus81-Mms4 (Figures 1 and 2). The lack
of visible Mms4 phosphorylation suggests that Mus81-
Mms4 remained with low activity during S-phase,
despite the presence of DNA damage. Finally, cells were
released from G1-arrest in medium with MMS for 60min,
and the MMS was then removed so that the culture could
recover and progress through the cell cycle (Figure 4C).
Phosphorylation of Mms4 was detected 75min after
removing the MMS, when most cells had a 2C DNA
content (Figure 4C), suggesting that Mus81-Mms4
becomes active only at the end of S-phase or in G2/M,
despite the previous presence of damaged DNA. Together,
these results indicate that Mms4 phosphorylation is not
induced by DNA damage and that only occurs when cells
ﬁnish S-phase.
To conﬁrm directly that DNA lesions during S-phase do
not induce Mus81-Mms4 activation, we performed
nuclease assays (Figure 4D–F). An HA-MMS4 culture
was blocked in G1 and split into three parts: one part
was released in medium without MMS for 20min (cells
in S-phase, no DNA damage), another one in medium
without MMS but containing nocodazole for 60min
(cells in G2/M, no DNA damage) and the third one in
medium with MMS for 60min (cells in S-phase, DNA
damage). In the latter, the MMS was subsequently
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removed and the cells were allowed to progress for
120min to reach the 2C DNA content. All cultures were
monitored by ﬂow cytometry (Figure 4D) and budding
index estimation. As shown in the immunoblot
(Figure 4E), Mms4 was not hyperphosphorylated in cells
in S-phase, regardless of having been treated with MMS,
in agreement with data in Figure 4A–C. However, when
MMS-treated cells were released from the drug and
allowed to reach the end of S-phase, Mms4 was hyperpho-
sphorylated, consistent with Figure 4C, and like in
G2/M-blocked cells that were used as a positive control.
In each case, HA-Mms4 was immunoprecipitated from
the cell extracts (Figure 4E) and the nuclease activity
was tested (Figure 4F). For the assays, we used two
different 32P-labelled synthetic structures that are sub-
strates of Mus81-Mms4 and are generated during DNA
replication or DNA replication-associated repair: a model
RF and a 30-FL. Mms4 is a non-catalytic subunit, but it
was shown that the immunoprecipitation (IP) of Mms4
from extracts yields nuclease activity and, therefore, the
Mus81-Mms4 complex immunoprecipitates and is func-
tional under these conditions (65). Figure 4F shows that
the nuclease activity of Mus81-Mms4, determined by the
appearance of clear labelled products, was only high when
Mms4 was immunoprecipitated from extracts obtained
from cells that had ﬁnished S-phase after MMS treatment.
This activity was similar to that of Mus81-Mms4 taken
from G2/M arrested cells that had not been treated
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previously with DNA damage. However, when Mms4 was
immunoprecipitated from S-phase cells treated with
MMS, or from untreated S-phase cells, the nuclease
activity was low. These results show that, although
Mus81-Mms4 is necessary for cells to cope with DNA
lesions originated during S-phase by MMS, DNA
damage does not induce the activation of the nuclease,
whose full activity is restrained until cells ﬁnish bulk
genome replication, like in an unperturbed cell cycle.
The absence of Sgs1 or Yen1 does not have an effect on
Mus81-Mms4 regulation
As mentioned previously, Mus81-Mms4 functionally
overlaps with Sgs1-Top3-Rmi1 and is required for cell via-
bility in the absence of this RecQ-helicase complex
(13,15,24–26). It is possible that most common substrates
for Mus81-Mms4 and Sgs1-Top3-Rmi1 are resolved by dis-
solution by the latter, but that they need to be processed by
Mus81 when the RecQ complex is not functional. In fact,
some DNA intermediates that persist after MMS treatment
in Rmi1-deﬁcient cells or in the absence of Sgs1 can be
removed by Mus81-Mms4 (66,44). Likewise, the sensitivity
of sgs1 cells to some DNA-damaging agents like MMS
increases when Mus81-Mms4 is not fully active (43).
Mus81-Mms4 has also overlapping functions with the
Yen1 resolvase during DNA repair, and cells lacking both
Mus81 and Yen1 show hypersensitivity to DNA-damaging
drugs (29–32). Due to these functional links, we asked
whether the absence of Sgs1-Top3-Rmi1 and Yen1 has an
effect on Mus81-Mms4 regulation, as it was possible that
this endonuclease could be required under these patho-
logical circumstances at times at which normally is not.
To address this question, sgs1HA-MMS4 cells were
blocked in G1 and released into medium without or
with MMS (Figure 5A). Flow cytometry indicates that
these cells progressed normally through S-phase in the
absence of the drug and slowly when exposed to MMS.
The immunoblot shows that, in the absence of MMS, the
cell cycle–dependent phosphorylation of Mms4 was like in
SGS1+ cells (Figure 4A). Likewise, like in SGS1+ cells
(Figure 4B), Mms4 did not show an electrophoretic
mobility shift when the sgs1 cells were treated with
MMS in S-phase. We also analysed Mms4 phosphoryl-
ation under the same conditions in sgs1yen1HA-
MMS4 cells (Figure 5B). G1-blocked cells were released
into medium without or with MMS. These cells pro-
gressed in S-phase similarly to SGS1+YEN1+ (Figure 4A
and B) and sgs1 cells (Figure 5A), both in the absence or
the presence of MMS. The immunoblot (Figure 5B) shows
that when the sgs1yen1 cells were not treated with
MMS, Mms4 phosphorylation occurred as in
SGS1+YEN1+ cells (Figure 4A), whereas Mms4 did not
present electrophoretic mobility changes indicative of
phosphorylation when the cells were exposed to MMS in
S-phase. These results indicate that the absence of Sgs1 or
Yen1 does not cause changes in the dynamics of activation
of this endonuclease, even in the presence of DNA damage
during chromosome replication. Moreover, these data also
show that the hyperphosphorylation of Mms4 does not
increase in budding yeast cells lacking Sgs1 with respect
to SGS1+ cells (compare Figures 4A and 5A), unlike
Eme1Mms4 phosphorylation in S. pombe (46). Mms4 phos-
phorylation does not increase either in the absence of both
Sgs1 and Yen1 (compare Figures 4A and 5B).
Next, to conﬁrm the above data, we assayed Mus81-
Mms4 nuclease activity (Figure 5C–E). The sgs1HA-
MMS4 and sgs1yen1HA-MMS4 cells were arrested in
G1; the cells were then released from the block for 60min,
either in the presence of MMS (cells in S-phase, DNA
damage) or in medium without MMS plus nocodazole
(cells in G2/M, no DNA damage). The cultures were moni-
tored by ﬂow cytometry (Figure 5C) and microscopy. The
immunoblots (Figure 5D) show that Mms4 was not
hyperphosphorylated in the extracts of S-phase cells
treated with MMS, in agreement with data in Figure 5A
andB. On the contrary,Mms4was hyperphosphorylated in
both strains in cells in G2/M. In each case, HA-Mms4 was
immunoprecipitated from the cell extracts (Figure 5D), and
the nuclease activity was analysed. Figure 5E shows that in
sgs1 and sgs1yen1 strains, the nuclease activity of
Mus81-Mms4 was low when the complex was immunopre-
cipitated from S-phase cells treated with MMS. However,
when Mms4 was immunoprecipitated from G2/M-cells,
Mus81-Mms4 activity was more robust, as shown by the
appearance of signiﬁcant amount of labelled products from
the substrates used. Therefore, the mode of regulation of
Mus81-Mms4 is not apparently altered when cells lack Sgs1
or Yen1, even in the presence of damaged DNA during S-
phase. Thus, even when the function of Mus81-Mms4
becomes more important to respond to DNA damage
due to the absence of Sgs1 (43), the full activity of the endo-
nuclease is still prevented until bulk DNA synthesis is
completed.
Mus81-Mms4 functions after completion of bulk DNA
replication to respond to DNA damage present in S-phase
As Mus81-Mms4 activation occurs only at the end of
S-phase despite the previous originated DNA damage,
we reasoned that the problems caused by MMS during
replication in the absence of this endonuclease should be
reversed by new expression of the complex before the cells
were plated for viability analysis. To test this hypothesis,
we made a strain in which the endogenous MUS81 and
MMS4 were placed under control of the GAL1-10
promoter to allow their conditional expression. To char-
acterize this strain, the sensitivity of PGAL1-10-MUS81
PGAL1-10-MMS4 cells to MMS was analysed in medium
with glucose or galactose. Figure 6A shows that these cells
grew normally in medium without MMS and behaved like
a mus81mms4 mutant in medium with MMS and
glucose (GAL-1,10 promoter OFF). However, in
medium with galactose (GAL-1,10 promoter ON), these
cells increased notably their resistance to MMS with
respect to mus81mms4. This result indicates that the
induced expression of Mus81 and Mms4 in the same strain
reconstitutes a functional complex, at least to an extent
that allows our experimental approach.
To analyse the reversibility of the problems caused by
MMS in S-phase cells lacking Mus81-Mms4, PGAL1-10-
MUS81 PGAL1-10-MMS4 cells were grown in medium
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with rafﬁnose (GAL1-10 promoter inactive), synchronized
in G1 and then released into medium containing rafﬁnose,
either without or with MMS. After 90min, the culture
containing MMS was divided: one part was held in
medium with rafﬁnose plus MMS; in the others, the
MMS was removed and the cells were transferred to
medium either with rafﬁnose or with galactose. The induc-
tion with galactose was also carried out 3 and 4 h after
eliminating the MMS (a scheme of the experiment is
drawn in Figure 6B). Cell cycle progression was
followed by ﬂow cytometry (Figure 6C) and the expres-
sion of Mus81 and Mms4 was monitored by immunoblot
(Figure 6D). Cell viability was estimated at the indicated
time points (Figure 6E).
Cells lacking Mus81 and Mms4 progressed normally
through several cell cycles after release from the G1
block in medium without MMS (Figure 6C, panel 1). In
contrast, these cells progressed slowly through S-phase in
the presence of MMS (Figure 6C, panel 2), which was
accompanied by a high loss of viability (Figure 6E).
Thus, PGAL1-10-MUS81 PGAL1-10-MMS4 cells, under re-
pressive conditions for the GAL1-10 promoter, behaved
similarly to a mus81mms4 strain in a medium with
glucose (Figure 1). After MMS removal in the continued
absence of Mus81 and Mms4, the cells progressed through
S-phase and reached the 2C DNA content (Figure 6C,
panel 3). However, the cells did not recover viability
and, even 8 h after removing the MMS, did not
complete the cell cycle. When PGAL1-10-MUS81 PGAL1-10-
MMS4 cells were transferred to galactose medium lacking
MMS (Figure 6C, panel 4), Mus81 and Mms4 were
induced within an hour (Figure 6D). At different times,
on release into galactose medium lacking MMS, cell via-
bility was monitored on YPGal medium (Supplementary
Figure S2A), or on YPD medium that repressed expres-
sion of Mus81 and Mms4 once again (Mus81 and Mms4
were degraded rapidly under such conditions, as shown in
Supplementary Figure S2B). Importantly, the viability
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Figure 5. Mus81-Mms4 regulation is not modiﬁed in cells lacking Sgs1 or Yen1. (A) sgs1HA-MMS4 cells (YMG21 strain) were synchronized in
G1 and then released into fresh medium ±MMS (0.02%). Cell cycle progression was monitored by ﬂow cytometry (left). Immunoblot analysis of
Mms4 (right). (B) G1-blocked sgs1yen1HA-MMS4 cells (YSG56 strain) were released into fresh medium ±MMS (0.02%). Left: Flow cytometry.
Right: Immunoblot analysis of Mms4. (C) Cell cycle experiments for the nuclease assays. Cells were synchronized in G1 and released in medium with
MMS (0.02%) for 60min or in medium without MMS (plus nocodazole). (D) The extracts were prepared from cells taken at the indicated time
points and HA-Mms4 was immunoafﬁnity puriﬁed. Mms4 was analysed by immunoblot in the whole cell extracts (WCE), and the yield of the IP was
estimated. About 2% of the total amount of the IP protein used for the nuclease assays was loaded. (E) The nuclease activity was assayed by the
resolution of a model RF and a 30-FL. The arrows indicate the labelled products resulting from the cleavage of each substrate. The controls were a
reaction without extract and a nuclease assay using IP-extracts from untagged cells blocked in G2/M.
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was only restored when Mus81 and Mms4 were expressed
several hours after release from MMS, around the time
that cells reached the end of S-phase (Figure 6C, panel 4).
This strongly suggests that Mus81-Mms4 only carries out
its function in the response to DNA damage after bulk
DNA synthesis.
To further demonstrate that Mus81-Mms4 works after
bulk DNA replication to respond to DNA damage present
in S-phase, its expression was induced when the cells had a
2C DNA content, rather than just after eliminating the
MMS. Thus, 3 and 4 h after MMS removal (Figure 6C,
panels 5 and 6, respectively), part of the culture growing in
rafﬁnose medium was transferred to medium with galact-
ose. The immunoblot (Figure 6D) shows that both
subunits were expressed within an hour. Flow cytometry
(Figure 6C) and microscopy analysis indicated that in
both cases cells ﬁnished S-phase and started dividing.
Regardless of the time of Mus81-Mms4 induction after
MMS removal, cell viability was signiﬁcantly restored
(Figure 6E). Moreover, the recovery of viability
occurred progressively but started as soon as the expres-
sion of Mus81-Mms4 was induced, unlike the case when it
was expressed just after eliminating the MMS. Likely, this
is because now the cells were already at the end of S-phase,
A
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Figure 6. Mus81-Mms4 functions after bulk DNA synthesis to respond to DNA damage originated in S-phase. (A) Sensitivity to MMS. Serial
dilutions (10-fold) of normalized log-phase cultures were spotted onto YP-Glucose or YP-Galactose plates containing the indicated amounts of MMS
and incubated at 30C for 48–72 h. MUS81+MMS4+ (W303-1a strain); mus81 mms4 (YMV49 strain); 3HA-MUS81, 3HA-MMS4 (YSG24 strain);
GAL-3HA-MUS81, GAL-3HA-MMS4 (YSG23 strain). (B) Scheme of the experiment. Numbers on the right correspond to those on the ﬂow
cytometry panels and in the graphic of cell viability. (C) Cell cycle progression was followed by ﬂow cytometry. Roman numerals indicate the
time points at which protein samples were taken for immunoblot analysis (D). (E) Cell viability analysis.
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when Mus81-Mms4 executes its function to respond to
DNA damage according to our data.
Together, these results indicate that the consequences of
the absence of the Mus81-Mms4 endonuclease during rep-
lication of a damaged DNA template are largely reversible
by new expression of this complex. Furthermore, these
data show that Mus81-Mms4 operates after bulk DNA
synthesis to allow cells to cope with DNA damage that
originated during chromosomal replication, consistent
with the results shown in Figures 4 and 5. It thus
appears that Mus81-Mms4 function is temporally separ-
able from bulk genome replication.
DISCUSSION
We have shown in this work that the structure-speciﬁc
Mus81-Mms4 endonuclease has a key role in the success-
ful completion of chromosome replication under condi-
tions of DNA damage. Furthermore, we have found
that this crucial function for cell survival is strictly
controlled, and that Mus81-Mms4 responds to DNA
lesions that occur during S-phase and hinder RF progres-
sion after the bulk of genome replication has been
ﬁnished.
Our data indicate that the problems for ﬁnishing repli-
cation in DNA-damaged cells lacking Mus81-Mms4 are
not due to massive fork collapse or lasting and extended
fork stalling. Instead, they more likely reﬂect the result of
relatively infrequent events. Nevertheless, these are quali-
tatively important, as they account for the incompletion of
chromosome replication and the high loss of viability in
mus81 mutants after treatment with a DNA-damaging
agent like MMS in a single S-phase.
Our results also show that budding yeast Mus81-Mms4
is not required for coping with every kind of perturbation
that causes fork block. We have shown that Mus81-deﬁ-
cient cells resume DNA replication normally after fork
stalling originated by HU, without loss of viability.
Therefore, it is unlikely that, at least in S. cerevisiae,
Mus81-Mms4 is involved in the cleavage of stalled
forks to initiate recombination-dependent fork restart.
This is consistent with the fact that recombination is not
necessary to complete S-phase after HU arrest (67).
Furthermore, in agreement with these data, Mus81-
Mms4 shows low activity in cells blocked with HU (43),
and in S. pombe, Mus81 is displaced from chromatin after
HU treatment in a Cds1-dependent manner (17). These
results are apparently in contradiction with data from
mammalian cells, showing that Mus81-Eme1 cleaves
stalled forks following HU exposure (62,63), which is
proposed to allow fork restart (62). The different results
may reﬂect distinct responses to stalled RFs between yeast
and higher eukaryotes. They may also likely indicate dif-
ferences between an acute, short HU treatment in our
experiments and prolonged HU exposure in those with
mammalian cells. In fact, long, but not short, HU treat-
ment can increase the amount of DNA damage and fork-
associated DSB (68,69). Mus81-dependent fork cleavage
after HU exposure has also been found under pathological
situations (70–72), but these are not present in our experi-
mental approach.
MMS causes DNA lesions that trigger fork pausing
(54,61,73,74). The fact that Mus81-Mms4 is not required
for restart after fork stalling caused by HU makes also
unlikely that its role to respond to MMS-induced lesions
during replication involves fork cleavage. Instead, it is
more probable a function for Mus81-Mms4 in processing
DNA intermediates that originate during DNA replica-
tion or DNA replication-associated repair, the resolution
of which is necessary for ﬁnishing chromosome duplica-
tion. Several pathways, including base excision repair,
homologous recombination and post-replication repair,
are required for replication through DNA lesions
produced by MMS (61). These pathways generate poten-
tial Mus81-Mms4 substrates during the removal of DNA
damage, some of which need probably to be resolved at
some point by this endonuclease to allow completion of
DNA repair and chromosome replication.
The data presented in this work indicate that DNA
lesions produced during S-phase do not modify the
mode of activation of Mus81-Mms4 that occurs in a
normal cell cycle. Mms4 phosphorylation and acquisition
of full endonuclease activity in cells treated with MMS
during S-phase remain restrained until they ﬁnish bulk
genome replication, and therefore the regulation of
Mus81-Mms4 under DNA-damaging conditions that
interfere with DNA replication is like in an unperturbed
cell cycle (42,43). Moreover, the absence of the RecQ-
helicase Sgs1 or the Yen1 resolvase, proteins with which
Mus81-Mms4 functionally interacts, does not have an
apparent effect on Mus81-Mms4 regulation. Therefore,
the regulation of Mus81-Mms4 through Mms4 phosphor-
ylation is independent of the presence of DNA damage
during chromosome replication, even if the number of
DNA lesions could accumulate due to pathological situ-
ations originated by the absence of proteins with which it
has overlapping functions. A recent work has shown that,
in S. pombe, Eme1Mms4 phosphorylation is increased in
G2 by damage induced by camptothecin or bleomycin,
which is accompanied by enhanced activity of Mus81-
Eme1 (46). However, our work indicates that MMS does
not induce or modify the phosphorylation of budding
yeast Mms4 and therefore the activity of Mus81-Mms4.
Furthermore, in budding yeast, the treatment with other
DNA-damaging drugs during S-phase or in G2/M does
not have a detectable effect on the cell cycle–dependent
phosphorylation of Mms4 (Supplementary Figure S3).
These results, together with the fact that Eme1-phosphor-
ylation in S. pombe is Plk1-independent (46), unlike Mms4
in budding yeast and human cells (42–44), clearly show
differences in the mode of regulation of Mus81-Eme1/
Mms4 among different organisms. They reﬂect distinct
successful evolutionarily strategies and make important
the study of these mechanisms in different systems.
Our results have indicated that the function of Mus81-
Mms4 during the response to DNA damage is only
executed after the bulk of genome replication is
completed. Supporting this conclusion, we have addition-
ally shown that new expression of Mus81-Mms4 signiﬁ-
cantly restores cell viability that is lost in the absence of
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this complex after MMS treatment, and that the function
of the endonuclease is only carried out when the cells are
at the end of S-phase, regardless of when the complex is
newly synthesized. The post-replicative function of
Mus81-Mms4 has a number of advantages that help to
maintain genome stability. Thus, preventing its nucleolytic
action during S-phase avoids the counterproductive
cleavage of DNA structures during chromosome replica-
tion, like RFs. Furthermore, the low Mus81-Mms4
activity during S-phase, even when the DNA is
damaged, avoids the undesired cleavage of DNA inter-
mediates during DNA repair that can lead to chromo-
somal rearrangements and high levels of sister chromatid
exchange. Indirectly, the absence of high Mus81-Mms4
activity in S-phase favours the action of the non-
nucleolytic resolution pathway mediated by Sgs1-Top3-
Rmi1, which does not originate crossovers or potential
chromosome reorganizations. Likewise, timely activation
of Mus81-Mms4 provides a safeguard mechanism that
guarantees, just before chromosome segregation, the reso-
lution of DNA intermediates that cannot be resolved by
other proteins and need to be processed for proper com-
pletion of DNA repair and chromosome replication. This
nucleolytic action can still put cells at some risk of
genomic instability, but it constitutes the necessary last
resort to resolve persistent intermediates that in any
case, under non-pathological situations, should not be
high in number. Finally, as the Mus81-Mms4 function is
uncoupled from bulk genome replication, it is also
expected that the proposed role of Mus81-Eme1/Mms4
in post-replication gap repair (11) is facilitated.
As the key aspects of the regulation of Mus81-Eme1/
Mms4 in an unperturbed cell cycle seem to be conserved
between budding yeast and human mitotic cells (42), it is
likely that the main results presented in this work can be
extrapolated to human cells suffering DNA damage. The
correct function of Mus81-Eme1/Mms4 is necessary to
prevent genomic instability, a hallmark of cancer (75).
Although it is unclear whether Mus81 is important to
avoid tumorigenesis (19,20), Mus81-associated defects
have been linked to some types of cancers (76,77), and
this endonuclease has been involved in oncogene-induced
genotoxicity (78,79). Therefore, it would be interesting to
study deeper whether the regulation of this endonuclease
fails in some tumour cells. Future work will be necessary
to explore the possible potential of Mus81-Eme1 as a
tumour marker and to gain information that may help
in the improvement of anti-cancer therapy.
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